Lana Pine

Results emphasized the challenges faced in accessing care and the impact on mental health for patients with rheumatic diseases.

A modification of DAS28 was shown to more accurately represent disease activity in patients with rheumatoid arthritis and concomitant fibromyalgia.

Patients with rheumatoid arthritis and high disease activity were more likely to be diagnosed with depression and fibromyalgia when compared with those in remission.

After 12 weeks of treatment, the median sUA levels of patients with gout were reduced from 8.6 mg/dL to 3.6 mg/dL in the AR882 75 mg cohort and 5.0 mg/dL in the AR882 50 mg group.

Results of the SELECT-AXIS 2 study supported the efficacy and safety profile of upadacitinib in patients with active ankylosing spondylitis who had an inadequate response to biologic DMARD therapy.

Over a 3-year period, patients treated with upadacitinib reported greater disease improvements and a greater mean change from baseline when compared with those receiving adalimumab.

Response rates in the DISSOLVE I and DISSOLVE II high-dose and low-dose groups receiving SEL-212 were significantly different from the placebo group.

Patients receiving 6MP prophylaxis experienced significantly reduced incidence of arthromyalgia and Health Assessment Questionnaire worsening of 22% or increase of .25.

In patients with systemic lupus erythematosus receiving rituximab and belimumab, Black and Indo-Asian patients were less likely to obtain major clinical response.

Janssen's efforts are accompanied by extensive data generation in patients of color and the creation of a diverse workforce.

In today’s episode, we explore how the lived experience of someone with rheumatoid arthritis can systematically be documented via the use of patient-reported outcome measures.

The podcast will explore the personal experiences of people living with rheumatic diseases and the latest research evidence that informs their diagnosis and treatment.

Janssen aims to address health inequities and promote culturally competent care.

The disparities compelled them to launch Determi-Nation, which utilizes healthcare providers, advocates, and patients within the psoriatic disease community to co-create solutions that address the observed inequities.

Statistically significant improvements were observed in all 10 PROMIS domains analyzed.

The analyses emphasized the early and sustained resolution of enthesitis through 52 weeks with both adalimumab and secukinumab.

A fibromyalgia diagnosis was significantly associated with GERD, IBS, Crohn’s disease, ulcerative colitis, and celiac disease.

Significant improvements in pain intensity, health-related quality of life, and depression were observed in patients receiving an online pain management intervention.

At the 12-week mark, the change from baseline in the DAS28-CRP was significantly greater in patients with rheumatoid arthritis receiving 700 mg peresolimab when compared with the placebo group.

At the 2-year mark after methotrexate initiation, 71% of patients with psoriatic arthritis and 76% of patients with rheumatoid arthritis remained on methotrexate.

Patients with fibromyalgia reported significantly less recreational, transportation-related, and total physical activity levels when compared with controls.

In addition to demonstrating efficacy, the numbers and incidence rates of treatment-emergent adverse events and treatment-emergent infections decreased throughout the 10-year follow-up.

Pooled results proved that telerehabilitation improved the Fibromyalgia Impact Questionnaire score and quality of life in patients with fibromyalgia when compared with controls.

At the 12-month mark, 52% of patients in the axSpA cohort and 76% of those in the IBD cohort achieved clinical remission.

Results highlight the need for physicians to consider rheumatoid arthritis in patients with microscopic colitis presenting with arthralgia or other joint symptoms.

Chronic tophaceous gout was demonstrated to be an independent risk factor linked to the development of colorectal cancer.

A maternal rheumatoid arthritis (RA) diagnosis before delivery was linked to an increased risk of offspring with autism spectrum disorder, particularly for those with seronegative RA.

The use of traditional Chinese medicine had a statistically significant association with improved clinical indicators in patients with rheumatoid arthritis.

A Cox regression analysis showed a significant association between a gout diagnosis and subsequent breast cancer diagnosis in the total population.

Themes related to coping with fibromyalgia included emotional coping, practical coping, and coping with the social environment.